Evolus to Participate in September Conferences
29 Agosto 2023 - 9:45AM
Business Wire
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
focus on building an aesthetic portfolio of consumer brands, today
announced that members of its management team will be participating
in two investment conferences in September.
Event: H.C. Wainwright 25th Annual Global
Investment Conference Date: Tuesday, September 12, 2023 Time: 11:00
– 11:30 am ET
Event: Cantor 2023 Global Healthcare
Conference Date: Tuesday, September 26, 2023 Time: 9:10 – 9:40 am
ET
Audio webcasts of these events will be available on the investor
relations section of Evolus’ website at www.evolus.com. Replays of
the webcasts will be available for 90 days after the date of each
presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving
the aesthetic neurotoxin market for the next generation of beauty
consumers through its unique, customer-centric business model and
innovative digital platform. Our mission is to become a global,
multi-product aesthetics company based on our flagship product,
Jeuveau® (prabotulinumtoxinA-xvfs), globally licensed under the
brand name Nuceiva®. The product is manufactured in a
state-of-the-art facility using Hi-Pure™ technology. Evolus is
expanding its product portfolio having entered into a definitive
agreement to be the exclusive U.S. distributor of Evolysse™, a line
of five unique dermal fillers currently in late-stage development.
Visit us at www.evolus.com, and follow us on LinkedIn, Twitter,
Instagram or Facebook.
Jeuveau® and Nuceiva® are registered trademarks of Evolus, Inc.
Evolysse™ is a trademark of Evolus, Inc. Hi-Pure™ is a trademark of
Daewoong Pharmaceutical Co, Ltd.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230828748089/en/
Investor Contacts: David K.
Erickson Vice President, Investor Relations Tel: 949-966-1798
Email: david.erickson@evolus.com
Ned Mitchell Arbor Advisory Group
Email: ir@evolus.com
Media Contact: Email:
media@evolus.com
Evolus (NASDAQ:EOLS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Evolus (NASDAQ:EOLS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024